Search

everythinglearnresearchcommunity

for

Search:↓

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Tofacitinib may effectively treat folliculitis decalvans.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Methotrexate is not proven to maintain remission in ulcerative colitis.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

A woman with skin eruptions and hair loss improved significantly with ointment treatment.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

PRF lysates reduce inflammation in cancer cells and boost immune response in healthy oral cells.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Tofacitinib effectively treats Alopecia Areata.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

JAK inhibitors show promise for treating various skin diseases.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Strong skin creams work well for long-term scalp inflammation in Rapp-Hodgkin Ectodermal Dysplasia.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.